Julie Grisham

Investigators are studying a rare ovarian tumor called sclerosing stromal tumor, a benign tumor that can be misdiagnosed as cancer.

A recent study found that only a quarter of women with breast cancer and a third of women with ovarian cancer had undergone genetic testing. Memorial Sloan Kettering experts say these numbers are surprisingly low.